Knight Theron T, Gonzalez Jose Andres, Rary John M, Rush Daniel S
Department of Surgery, James H. Quillen College of Medicine, East Tennessee State University, P. O. Box 70575, Johnson City, TN 37614, USA.
Am J Surg. 2006 Jan;191(1):104-10. doi: 10.1016/j.amjsurg.2005.10.010.
Carotid body tumor (CBT) is a rare lesion of the neuroendocrine system. Chronic hypoxia has long been recognized as an etiology of CBT and other paragangliomas. Recent biogenetic discoveries reveal that mutations in oxygen-sensing genes are another etiology, accounting for approximately 35% of cases, and that these 2 etiologies are probably additive.
(1) A retrospective analysis of fifteen cases of CBT in a 6-year period occurring in the mountains of Southern Appalachia; (2) an extensive review of the literature on the surgery of CBT and on the expansive biogenetic understanding of the disease.
Improved imaging, vascular surgical techniques, and understanding of the disease have vastly improved outcomes for patients. The necessities for long-term follow-up and appropriate genetic testing and counseling of patients and their families are documented. Surgeon and institutional competence are critical in achieving maximal outcomes.
颈动脉体瘤(CBT)是神经内分泌系统的一种罕见病变。长期以来,慢性缺氧一直被认为是CBT及其他副神经节瘤的病因。最近的生物遗传学发现表明,氧感应基因的突变是另一种病因,约占病例的35%,并且这两种病因可能是累加的。
(1)对阿巴拉契亚山脉南部山区6年内发生的15例CBT病例进行回顾性分析;(2)对有关CBT手术及对该疾病广泛的生物遗传学认识的文献进行广泛综述。
改进的影像学、血管外科技术以及对该疾病的认识已极大地改善了患者的治疗效果。记录了对患者及其家属进行长期随访以及适当的基因检测和咨询的必要性。外科医生和机构的能力对于实现最佳治疗效果至关重要。